Oncology Medical Writing Svcs Inc New York City, NY - 10023

Oncology Medical Writing Svcs Inc is categorized under Services (Unclassified) in New York City, NY and active since 2009.

Oncology Medical Writing Svcs Inc was established in 2009, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.

If you are seeking more information, feel free to contact Susan Kralian at the company’s single location by writing to 239 West 63rd St Apartment 1e, New York City, New York NY 10023 or by phoning (212) 362-3891. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Oncology Medical Writing Svcs Inc
Contact Person: Susan Kralian
Address: 239 West 63rd St Apartment 1e, New York City, New York 10023
Phone Number: (212) 362-3891
Annual Revenue (USD): $0 to $49.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Services (Unclassified)
SIC Code: 8999
NAICS Code: 541990
Share This Business:

Oncology Medical Writing Svcs Inc was started in 2009 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.

Feel free to contact Susan Kralian for inquiries that concern Oncology Medical Writing Svcs Inc by calling the company number (212) 362-3891, as your correspondence is most welcome. Additionally, the physical location of the single location of Oncology Medical Writing Svcs Inc can be found at the coordinates as well as the street address 239 West 63rd St Apartment 1e in New York City, New York 10023.

For its online presence, you may visit Oncology Medical Writing Svcs Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.